Virtus Investment Advisers, Inc. Oric Pharmaceuticals, Inc. Call Options Transaction History
Virtus Investment Advisers, Inc.
- $289 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ORIC
# of Institutions
144Shares Held
75.9MCall Options Held
11.3KPut Options Held
2.7K-
Viking Global Investors LP6.57MShares$34.8 Million0.12% of portfolio
-
Nextech Invest, Ltd. Zurich, V85.29MShares$28 Million6.85% of portfolio
-
Nextech Invest Ag5.29MShares$28 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$25.6 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY4MShares$21.2 Million0.05% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $209M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...